Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b49b135f099e96a0e4cab2427a48ae8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_545f4a04e99fda7f4f0ec4949cb963e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f790e0fa57e652aa994a7cd44c94dbd3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1ed0faa8a366a7d23cba50510e9e4ac |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-364 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57411 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
filingDate |
2006-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_941cded78b17c4d571208e84bd4e9f7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51246e9b5b317ec0d07e5512d5e1d796 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f136d9f9da7456002e8468568cb37df |
publicationDate |
2006-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2006089219-A2 |
titleOfInvention |
Neoepitope detection of disease using protein arrays |
abstract |
A biosensor for use in detecting the presence of diseases, the biosensor comprising a detector for detecting a presence of at least one marker indicative of a specific disease. A method of determining efficacy of a pharmaceutical for treating a disease or staging disease by administering a pharmaceutical to a sample containing markers for a disease, detecting the amount of at least one marker of the disease in the sample, and analyzing the amount of the marker in the sample, whereby the amount of marker correlates to pharmaceutical efficacy or disease stage. Markers for gynecological disease selected from the list in Table 8. An immuno-imaging agent comprising labeled antibodies, whereby the labeled antibodies are isolated and reactive to proteins overexpressed in vivo. Informatics software for analyzing the arrays of claim 17, the software including analyzing means for analyzing the arrays. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106404975-A |
priorityDate |
2005-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |